Mylan Laboratories Limited — Sofosbuvir Exporter Profile
Indian Pharmaceutical Exporter · #1 for Sofosbuvir · $9.9M export value · DGFT Verified
Mylan Laboratories Limited is the #1 Indian exporter of Sofosbuvir with $9.9M in export value and 199 verified shipments. Mylan Laboratories Limited holds a 24.3% market share in Sofosbuvir exports across 44 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.
Mylan Laboratories Limited — Sofosbuvir Export Profile: Buyers & Destinations
Where Does Mylan Laboratories Limited Export Sofosbuvir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ETHIOPIA | $533.4K | 11 | 7.9% |
| KAZAKISTAN | $414.0K | 11 | 6.2% |
| GEORGIA | $408.6K | 9 | 6.1% |
| VIETNAM, DEMOCRATIC REP. OF | $400.0K | 8 | 5.9% |
| TURKMENISTAN | $392.9K | 10 | 5.8% |
| BELGIUM | $384.2K | 12 | 5.7% |
| CAMBODIA | $380.4K | 14 | 5.7% |
| MYANMAR | $310.8K | 9 | 4.6% |
| POLAND | $303.5K | 8 | 4.5% |
| PAKISTAN | $300.0K | 6 | 4.5% |
Mylan Laboratories Limited exports Sofosbuvir to 47 countries. The largest destination is ETHIOPIA accounting for 7.9% of Mylan Laboratories Limited's Sofosbuvir shipments, followed by KAZAKISTAN (6.2%) and GEORGIA (6.1%). These destinations reflect Mylan Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sofosbuvir from Mylan Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNDP OFFICE IN TURKMENISTAN | TURKMENISTAN | $392.9K | 10 |
| ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O | ETHIOPIA | $300.0K | 6 |
| WORLD HEALTH ORGANIZATION | AFGHANISTAN | $254.0K | 7 |
| TOO-L-PHARMA | KAZAKISTAN | $231.7K | 7 |
| UNOPS MYANMAR OC | MYANMAR | $200.0K | 4 |
| MSF SUPPLY C.V, | BELGIUM | $193.3K | 6 |
| TOO-"L-PHARMA", | KAZAKISTAN | $182.3K | 4 |
| NATIONAL TB CONTROL PROGRAM (NTP) | PAKISTAN | $150.0K | 3 |
| DELTA IMPORT EXPORT MEDICAL CO | VIETNAM | $150.0K | 3 |
| UNITED NATIONS DEVELOPMENT PROGRAMM | KYRGHYSTAN | $150.0K | 3 |
Mylan Laboratories Limited supplies Sofosbuvir to 99 buyers globally. The largest buyer is UNDP OFFICE IN TURKMENISTAN (TURKMENISTAN), followed by ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O (ETHIOPIA) and WORLD HEALTH ORGANIZATION (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sofosbuvir Export Value and How Much Does Mylan Laboratories Limited Contribute?
India exported $18.1M worth of Sofosbuvir through 1,341 shipments from 150 suppliers to 113 countries, serving 377 buyers globally. Mylan Laboratories Limited contributes $9.9M to this total, accounting for 24.3% of India's Sofosbuvir exports. Mylan Laboratories Limited ships Sofosbuvir to 47 countries through 99 buyers.
What Is the Average Shipment Value for Mylan Laboratories Limited's Sofosbuvir Exports?
Mylan Laboratories Limited's average Sofosbuvir shipment value is $50.0K per consignment, based on 199 shipments totaling $9.9M. The largest destination is ETHIOPIA (7.9% of Mylan Laboratories Limited's Sofosbuvir exports).
How Does Mylan Laboratories Limited Compare to Other Indian Sofosbuvir Exporters?
Mylan Laboratories Limited ranks #1 among 150 Indian Sofosbuvir exporters with a 24.3% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($9.9M), HETERO LABS LIMITED ($5.3M), NATCO PHARMA LIMITED ($800.0K). Mylan Laboratories Limited processed 199 shipments to 44 destination countries.
What Sofosbuvir Formulations Does Mylan Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SOFOSBUVIR 400MG + DACLATASVIR 60MG TABL | $203.7K | 5 |
| SOFOSBUVIR 400MG+DACLATASVIR 60MG TABLET | $176.9K | 7 |
| SOFOSBUVIR 400MG + VELPATASVIR 100MG TAB | $150.0K | 3 |
| SOFOSBUVIR 400MG + DACLATASVIR 60MG TABLETS 28'S - MYHEP DVIR 19749 PACKS X 28 NOS | $150.0K | 3 |
| SOFOSBUVIR 400MG + DACLATASVIR 60MG TABLETS 28'S - MYHEP DVIR 19749 PACKS X 28 NOS. | $150.0K | 3 |
| MYVELPA -- SOFOSBUVIR 400MG-VELPATASVIR 100MG 28BT 28'S BOTTLE | $150.0K | 3 |
| SOFOSBUVIR VELPATASVIR, TABLETS 400MG 100MG HDPE BOTTLE OF 28 PACKS 6600NOS | $150.0K | 3 |
| MYHEP ALL SOFOSBUVIR + VELPATASVIR 400MG100MG 28BT TAB PACKS 4763NOS | $150.0K | 3 |
| MY HEP SOFOSBUVIR TAB 400MG 28BT KZ MY PACK 17000NOS | $150.0K | 3 |
| Sofosbuvir 400mg + Daclatasvir 60mg Tabl | $138.0K | 3 |
Mylan Laboratories Limited exports 136 distinct Sofosbuvir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SOFOSBUVIR 400MG + DACLATASVIR 60MG TABL with 5 shipments worth $203.7K.
How Does Mylan Laboratories Limited Compare to Nearest Sofosbuvir Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED ★ | $9.9M | 199 | 44 | $50.0K |
| 2 | HETERO LABS LIMITED | $5.3M | 105 | 18 | $50.0K |
| 4 | NATCO PHARMA LIMITED | $800.0K | 16 | 7 | $50.0K |
Mylan Laboratories Limited ranks #1 among 150 Indian Sofosbuvir exporters. Average shipment value of $50.0K compared to the market average of $120.8K. The closest competitors by value are HETERO LABS LIMITED and NATCO PHARMA LIMITED.
Which Indian Ports Ship Sofosbuvir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 357 | 26.6% |
| SAHAR AIR | 269 | 20.1% |
| DELHI AIR CARGO ACC (INDEL4) | 158 | 11.8% |
| Bombay Air | 126 | 9.4% |
| DELHI AIR | 79 | 5.9% |
| AHEMDABAD AIR | 68 | 5.1% |
| AHEMDABAD AIR ACC (INAMD4) | 50 | 3.7% |
| HYDERABAD ACC (INHYD4) | 39 | 2.9% |
What Other Antiviral & HIV Medications Products Does Mylan Laboratories Limited Export?
Mylan Laboratories Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Sofosbuvir Exports
Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.
In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.
Mylan Laboratories Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.
The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.
About Mylan Laboratories Limited
Mylan Laboratories Limited exports 91 products worth $634.8M. Beyond Sofosbuvir, top products include Tenofovir, Pantoprazole, Valsartan, Ritonavir, Trastuzumab. View the complete Mylan Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sofosbuvir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sofosbuvir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 199 individual customs records matching Mylan Laboratories Limited exporting Sofosbuvir, covering 136 formulations to 47 countries via 99 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sofosbuvir Export Data from Mylan Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Mylan Laboratories Limited's Sofosbuvir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Mylan Laboratories Limited
Full Company Profile →
91 products · $634.8M total trade · 26 categories
Sofosbuvir Stats
Company Overview
Top Products by Mylan Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Mylan Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sofosbuvir. For current shipment-level data, contact TransData Nexus.